Navigation Links
Eurocine Vaccines Strengthens the Organization for Further Development
Date:4/7/2017

STOCKHOLM, April 7, 2017 /PRNewswire/ -- Eurocine Vaccines strengthens the organization with necessary competence, not only to prepare for further development of its first product, the nasal influenza vaccine candidate Immunose™ FLU, but also for further development of a pipeline of other vaccines based on the patented technology platform Endocine™.

"In parallel with finalizing the analyses and evaluation of the current study, we now prepare for the next steps of development. Reinforcing the organization with Sandra Jeldes Granstrand, a senior and experienced Project Leader of CMC[1], supports our ambitious strategy and rapid development ahead", said CSO Anna-Karin Maltais.

Simultaneously, CSO Anna-Karin Maltais is appointed Vice President Research and Development.

"This emphasizes our positive ambitions as we continue building value", said CEO Hans Arwidsson and continued "Ensuring that the next influenza season can be well used for further development, opens for a shorter way to market, to the benefit of patients and partners."

Results from the ongoing clinical study are expected in June/July 2017.

More information about the study can be found at www.clinicaltrials.gov.

[1] Chemistry Manufacturing and Control

CONTACT:
CEO of Eurocine Vaccines AB
hans.arwidsson@eurocine-vaccines.com  
+46-70-634-0171

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/eurocine-vaccines/r/eurocine-vaccines-strengthens-the-organization-for-further-development,c2235009

The following files are available for download:

http://mb.cision.com/Main/11552/2235009/654837.pdf

Se news release

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eurocine-vaccines-strengthens-the-organization-for-further-development-300436536.html


'/>"/>
SOURCE Eurocine Vaccines
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Animal Vaccines Market Expected to Reach $9,159 Million by 2022 - Allied Market Research
2. New Access to Vaccines Index Reveals First Landscape of Vaccine Company Actions to Improve Immunisation Coverage
3. Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025
4. Global Influenza Vaccines - World Industry Market Outlook 2017-2027
5. Research and Markets - Global Travel Vaccines Market 2016-2020: Market Growth at CAGR of 6.83% - Growing Demand Among Travelers / Additional Age Group Approval / Inclusion in NIP
6. Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
7. Global Influenza Vaccines Market and Forecast to 2021: North America Accounted for 50% of the $5 Billion Market in 2015 - Research and Markets
8. Research and Markets - Global H1N1 Vaccines Market Analysis 2016-2025 - Trends, Technologies & Opportunities Report 2016-2025 - Vendors: Novartis, Zydus Cadila, Merck
9. Vaccines a 28 Billion-Dollar Market, Kalorama Information Study Finds
10. Kalorama: After Allergan Merger Halt, Vaccines a Focus for Pfizer
11. Profectus and Vyriad Form Global Collaboration to Develop Oncolytic Recombinant VSV (rVSV) Vaccines for Cancer Immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2018)... ... November 15, 2018 , ... ... mix-and-match, packaged, and standalone ancillary benefits from the nation’s premier carriers. Previously, CoPower ... said, “More small employers have access to top tier company benefits now that ...
(Date:11/15/2018)... ... November 15, 2018 , ... The Bluntness Will Deliver ... Million Users , The Bluntness Furthers Maven’s Commitment to Innovative Cannabis Journalism & ... coalition of over 300 exclusive publishers and brands, powered by a unified publishing, ...
(Date:11/15/2018)... N.J. (PRWEB) , ... November 15, 2018 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... facility, will present at the upcoming Partnerships in Clinical Trials (PCT) conference at ...
Breaking Medicine Technology:
(Date:11/16/2018)... ... ... AP was selected in the Health Care 2 ($10-$30M) Category and will be ... Hyatt Regency Downtown Dallas along with other companies who have illustrated exceptional qualities during ... Annual Excellence in Construction National Level Competition through Associated Builders and Contractors, Inc (ABC). ...
(Date:11/16/2018)... ... November 16, 2018 , ... CapRock Health, the Brazos Valley’s ... first urgent care facility in the Century Square Development in College Station, Texas on ... for acute medical care to the Bryan and College Station area,” said Dr. Andy ...
(Date:11/16/2018)... ... November 16, 2018 , ... Author and thought ... Science Transformed the Art of Medicine (GreenLeaf Press, 2018) was recently awarded a ... , Interweaving moving personal patient stories with a historical overview that reveals ...
(Date:11/16/2018)... ... November 16, 2018 , ... It may surprise many people to learn ... To help provide care and support that reflect the important contributions made by these ... Honor Veterans, a pioneering campaign developed by National Hospice and Palliative Care Organization (NHPCO) ...
(Date:11/16/2018)... FORKS, N.D. (PRWEB) , ... November 16, 2018 ... ... medical marijuana dispensary licenses for the Grand Forks and Williston regions today. Dispensary ... LLC, which will be doing business as Strive Life in Grand Forks, North ...
Breaking Medicine News(10 mins):